Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PBK-1701TC (Orafang) for Bowel Cleansing
NCT03509220Phase 3Completed
- Sponsor
- Pharmbio Korea Inc.
- Start
- Apr 2018
- Primary completion
- Oct 2018
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Orafang in Gastrointestinal cleansing (2 arms), sponsored by Pharmbio Korea Inc. Primary endpoint: Successful cleansing rate at 2 days. Started Apr 2018; status: completed.
02
Drugs
Orafang
03
Conditions
Gastrointestinal cleansing
Beyond the preview
Go deeper on NCT03509220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03509220.